Abstract

Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Nilima Parry‐Jones ... Anna Schuh
British journal of haematology | VOL. 196
Nilima Parry‐Jones, et. al.Nilima Parry‐Jones ... Anna Schuh
08 Sep 2021
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block
J A Burger ... V Gandhi
Clinical Cancer Research | VOL. 15
J A Burger, et. al.J A Burger ... V Gandhi
14 Dec 2009
Impact of Atrial Fibrillation on Cardiovascular and Economic Outcomes in Patients with Chronic Lymphocytic Leukemia
Sizhu Liu ... Keri Yang
Blood | VOL. 138
Sizhu Liu, et. al.Sizhu Liu ... Keri Yang
05 Nov 2021
Real-world evidence of impact of atrial fibrillation (AF) on clinical and economic outcomes in patients with chronic lymphocytic leukemia (CLL).
Tom Liu ... Asher Chanan-Khan
Journal of Clinical Oncology | VOL. 40
Tom Liu, et. al.Tom Liu ... Asher Chanan-Khan
01 Jun 2022
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
Assessment of fatigue in adult patients with sickle cell disease: Useof the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
Geoffrey Cheminet ... Jean‐Benoît Arlet
British journal of haematology | VOL. -
Geoffrey Cheminet, et. al.Geoffrey Cheminet ... Jean‐Benoît Arlet
27 May 2024
View more papers